A researcher works in a Beijing Genomics Institute laboratory in Kunming, China, on Dec. 26, 2018. China has publicized a series of new regulations since a Chinese scientist claimed to have genetically engineered twins last year, but has not accounted for the scientist's alleged feat.
Since news broke in late November 2018 that Chinese scientist He Jiankui had used the gene-editing tool CRISPR to engineer twins to ensure heritable immunity to HIV, Beijing has implemented a multitiered response to address apparent shortcomings in Chinese laws. New regulations governing the protection and use of human genes, patients and embryos in preclinical and clinical research are coming into force, but do they mean real change for the country?...
TO READ THE FULL ARTICLE
Copyright © Stratfor Enterprises, LLC. All rights reserved.